Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| GID | Ann: GID Announces IRB Approval for EndoBarrier Pivotal Trial | 14/02/19 | 0 | 74 | |||
|
|||||||
| GID | Ann: Appendix 4C - quarterly | 31/01/19 | 0 | 85 | |||
|
|||||||
| GID | Ann: GID Appoints VP of Clinical and Regulatory Affairs | 04/01/19 | 0 | 137 | |||
|
|||||||
| GID | Ann: Extension of the Maturity Date of US $5M Convertible Note | 02/01/19 | 0 | 235 | |||
|
|||||||
| GID | News: GID GI Dynamics Appoints Charles Carter As CFO | 11/12/18 | 0 | 78 | |||
|
|||||||
| GID | Ann: GID Appoints Chief Financial Officer and Company Secretary | 11/12/18 | 0 | 81 | |||
|
|||||||
| GID | Ann: Change in substantial holding | 29/11/18 | 0 | 77 | |||
|
|||||||
| GID | Ann: Agreement with Apollo Sugar to Study EndoBarrier in India | 28/11/18 | 0 | 99 | |||
|
|||||||
ASX News
Hot NewsSee All Discussions
Timeline
|
|
||||
|
|
|
||||
|
|
|
||||
|
|
|
||||
|
|
|
||||
|
|
|
||||
| View More | |||||
 (20min delay)
|
|||||
|
Last
1.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $16.30M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500000 | 1.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 65968 | 3 |
View Market Depth
| Last update - 16.12pm 22/02/2019 (20 minute delay) ? |
| GID (ASX) Chart |
Day chart unavailable